Page last updated: 2024-12-05

diethylene glycol dimethacrylate monomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16891
CHEMBL ID3186638
SCHEMBL ID24260
MeSH IDM0137210

Synonyms (61)

Synonym
di(ethylene glycol) dimethacrylate, 95%
diethylene glycol bis(methacrylate)
tgm 2
methacrylic acid, oxydiethylene ester
dgm 2
oxydiethylene methacrylate
diethylene glycol dimethacrylate monomer
diethylene glycol dimethacrylate
oxydi-2,1-ethanediyl bismethacrylate
diethyleneglycol dimethacrylate
2-propenoic acid, 2-methyl-, oxydi-2,1-ethanediyl ester
einecs 219-099-9
hsdb 5458
ccris 7050
2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate
D1530
2358-84-1
2-propenoic acid, 2-methyl-, 1,1'-(oxydi-2,1-ethanediyl) ester
unii-r42pui926f
r42pui926f ,
tox21_301734
dtxsid8044882 ,
NCGC00256100-01
di(ethylene glycol) dimethacrylate
cas-2358-84-1
dtxcid6024882
25101-18-2
FT-0624887
AKOS015903120
diethylene glycol dimethacrylate [inci]
diethylene glycol bis(methacrylate) [hsdb]
methacrylic acid, diester with diethylene glycol
diethylene glycol, dimethacrylate
2,2'-oxybisethanol dimethacrylate
2,2'-oxydiethyl dimethacrylate
light ester 2eg
blemmer pde 100
SCHEMBL24260
diethyleneglycoldimethacrylate
XFCMNSHQOZQILR-UHFFFAOYSA-N
mfm-418
ageflex degdma
3-oxapentane-1,5-diyl dimethacrylate
2-[2-(methacryloyloxy)ethoxy]ethyl 2-methylacrylate #
CHEMBL3186638
diethylene glycol dimethacrylate(8 cp(20 degrees c))
mfcd00014931
diethylene glycol dimethacrylate, (stabilized with mehq)
di(ethylene glycol) dimethacrylate, 96%
diethylene glycol dimethacrylate (stabilized with mehq)
J-015158
2,2'-oxybis(ethane-2,1-diyl) bis(2-methylacrylate)
129011-76-3
Q27287772
oxybis(ethane-2,1-diyl) bis(2-methylacrylate)
BS-48957
oxybis(ethane-2,1-diyl)bis(2-methylacrylate)
2-{2-[(2-methylprop-2-enoyl)oxy]ethoxy}ethyl 2-methylprop-2-enoate
CS-W010276
E82986
2-methyl-2-propenoic acid oxidi-2,1-ethanediyl ester,homopolymer
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.64480.000229.305416,493.5996AID743069; AID743078
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency61.64480.023723.228263.5986AID743222
activating transcription factor 6Homo sapiens (human)Potency61.64480.143427.612159.8106AID1159516
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.48270.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.12 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]